3Bemardo A, Bali C, Nolasco L, et al. Effects of inflammatory cytokines on the release and cleavage of the endothelial cellderived ultra-large yon WiRe-brand factor multimers under flow [ J ]. Blood,2004,104 : 100 - 106.
4Vesely SK, George JN, Lammle B, et al. ADAMT13 activity in thrombotic thrombocytopenic purpura-hemolytic uremic syndrome:relation to pres enting features and clinical outcomes in a prospectiv ecohort of 142 patients [ J ]. Blood, 2003,102 : 60 - 68.
9Zhan H, Streiff MB, King KE, et al. Thrombotic thmmbocytopenic purpura at the Johns Hopkins Hospital from 1992 to 2008 : clinical outcomes and risk factors for relapse [J]. Transfusion, 2010, 50 (10): 868- 874.
10Gurkan E, Baslamisli F, Guvenc B, et al. Thrombotic thrombocytope- nic purpura in southern Turkey: a single - center experience of 29 cases [J]. Clin Lab Haematol, 2005. 27:121 - 125.
